首页 > 市场调查报告书 > 食物/饮料

动物饲料

市场调查报告书

商品编码

1448009

饲料抗生素市场 - 2023-2030

Feed Antibiotics Market - 2023-2030

出版日期: 2024年03月08日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球饲料抗生素市场规模达28亿美元，预计2030年将达到392万美元，2023-2030年预测期间CAGR为4.3%。

全球人口的成长和许多地区收入水准的提高导致肉类和乳製品消费量增加。据粮农组织称，到 2030 年，全球人均肉类消费量预计将每年增长 0.3%，达到零售重量当量 35.4 公斤。因此，对动物饲料（包括促进牲畜生长和健康的抗生素）的需求将会增加。

饲料抗生素通常用于提高牲畜生长速度并提高动物养殖中的饲料效率。透过促进更快的生长和有效的养分利用，农民可以更有效地满足全球对肉类和动物产品日益增长的需求。这种做法旨在最大限度地提高集约化农业系统的生产力。因此，人们对使用饲料抗生素的好处的认识不断提高是推动市场成长的关键趋势。

四环素类药物在全球饲料抗生素市场中发挥着至关重要的作用，由于其广泛用于促进牲畜生长和预防疾病，因此占了三分之一的份额。同时，亚太地区占据了同样重要的三分之一份额，这主要是由于对肉类和乳製品的需求不断增长所推动的。根据《中国简报》报道，2022年，中国人均猪肉消费量将超过5300万吨，牛肉和小牛肉消费量将超过1000万吨，成为全球最大的肉类消费国之一。

动力学

对动物性食品的需求不断增长

随着全球人口的成长和收入的增加，对肉类、乳製品和鸡蛋的需求不断增长。据粮农组织称，2018 年至 2030 年间，全球动物蛋白消费量预计将增加 14%。到 2030 年，绵羊、牛肉、猪肉和家禽肉中的蛋白质预计将增加 17.8%、5.9%。分别为%、 13.1% 和15.7%。为了保持这些动物的健康并促进生长，许多农民历来使用抗生素作为饲料添加剂，这推动了其需求。

抗生素在畜牧业中发挥多方面的作用，促进生长、预防疾病和促进治疗。工业化农业的拥挤和压力条件创造了疾病可以在动物之间迅速传播的环境。抗生素有助于预防这些疾病并降低牲畜死亡率，确保动物性食品的稳定供应。农民受益于这种效率，因为它减少了饲养动物所需的时间和资源。

增加动物保健支出投资

各国政府和私人投资者越来越认识到畜牧业的重要性，并投资于现代化畜牧生产设施，加强动物健康管理等。2020 年2 月，Elanco Animal Health Incorporated 宣布与默克动物保健公司(Merck Animal Health) 达成协议，转让Vecoxan 在全球范围内的权利。5500 万美元全现金安排。 Vecoxan 用于预防和治疗犊牛和羔羊的球虫病。这些类型的投资反过来推动了饲料抗生素市场的成长

抗生素在动物饲料中对于预防和控制疾病至关重要。健康的动物不仅生长得更快，而且生产效率更高，这对于满足对动物产品不断增长的需求至关重要。抗生素在减少人口稠密的畜牧设施中疾病爆发方面发挥着至关重要的作用，从而改善整体健康状况并提高生产力水平。因此，随着消费者对动物福利和牲畜抗生素使用意识的不断增强，对来自负责任地使用抗生素饲养的动物的产品的需求不断增长。

抗生素抗药性不断增强

抗生素的过度使用和滥用，包括在畜牧业的使用，导致了抗生素抗药性细菌的发展。这些抗药性病原体可以感染动物，并有可能透过食物链或环境污染传播给人类，造成重大的公共卫生风险。美国肉类研究所声称，食用接受抗生素治疗的动物的肉会导致人类抗菌素抗药性（对某些抗生素产生抗药性）。

世界各地的监管机构越来越关注抗生素抗药性及其对人类健康的影响。因此，许多国家推出了更严格的法规来管理畜牧业中抗生素的使用。例如，2022 年 1 月 28 日，欧盟实施了一项新法律，禁止对养殖动物进行常规饲餵抗生素。此类法规通常会限制可以使用的抗生素类型，从而限制畜牧业抗生素市场的成长。

Growing global populations and increasing income levels in many regions were leading to higher meat and dairy consumption. According to FAO, worldwide per capita meat consumption is expected to rise by 0.3% pa to 35.4 kg in retail weight equivalent by 2030. As a result, there is a greater demand for animal feed, including antibiotics to promote livestock growth and health.

Feed antibiotics were commonly employed to boost livestock growth rates and improve feed efficiency in animal farming. By promoting faster growth and efficient nutrient utilization, farmers could meet the increasing global demand for meat and animal products more effectively. This practice aimed to maximize productivity within intensive farming systems. Hence, rising awareness about the benefits of using feed antibiotics acts as a key trend for boosting market growth.

Tetracyclines play a crucial role in the global feed antibiotics market, constituting a significant one-third share due to their widespread use for promoting livestock growth and preventing diseases. At the same time, the Asia-Pacific region holds an equally substantial one-third share, mainly driven by the increasing demand for meat and dairy products. According to China Briefing, with an average per capita consumption of over 53 million tons of pork and 10 million tons of beef and veal, China was among the world's largest meat consumers in 2022.

Dynamics

Rising Demand for Animal-derived Food Products

There is a rising demand for meat, dairy, and eggs, as global populations grow and incomes rise. According to FAO, the consumption of animal proteins worldwide is anticipated to increase by 14% between 2018 and 2030. By 2030, it is anticipated that the protein available from meat from sheep, beef, pork, and poultry will increase by 17.8%, 5.9%, 13.1%, and 15.7%, respectively. To keep these animals healthy and promote growth, many farmers have historically used antibiotics as feed additives which drives its demand.

Antibiotics in animal agriculture serve a multifaceted role, promoting growth, preventing diseases, and facilitating treatment. The crowded and stressful conditions of industrial farming create an environment where diseases can quickly spread among animals. Antibiotics help prevent these diseases and reduce livestock mortality rates, ensuring a stable supply of animal-derived food products. Farmers benefit from this efficiency as it reduces the time and resources needed to raise animals for food.

Increasing Investment in Animal Health Expenditure

Governments and private investors are increasingly recognizing the importance of the livestock sector and are investing in modernizing livestock production facilities enhancing animal health management etc. In February 2020, Elanco Animal Health Incorporated announced an agreement with Merck Animal Health to transfer worldwide rights for the Vecoxan for USD 55 million in an all-cash arrangement. Vecoxan is used for the prevention and treatment of coccidiosis in calves and lambs. These types of investments in turn drive the feed antibiotics market growth

Antibiotics are crucial in animal feed for preventing and managing diseases. Healthy animals not only grow faster but also produce more efficiently, which is essential to meet the growing demand for animal products. Antibiotics play a vital role in minimizing disease outbreaks in densely populated livestock facilities, resulting in improved overall health and higher productivity levels. Hence with the growing consumer awareness of animal welfare, and antibiotic use in livestock there is a growing demand for products from animals raised with responsible antibiotic use.

Growing Resistance to Antibiotics

Overuse and misuse of antibiotics, including their use in animal agriculture, have led to the development of antibiotic-resistant bacteria. These resistant pathogens can infect animals and have the potential to transfer to humans through the food chain or environmental contamination, creating a significant public health risk. The American Meat Institute claims that eating meat from an animal that has received antibiotic treatment results in human antimicrobial resistance (resistance to certain antibiotics).

Regulatory bodies worldwide are increasingly concerned about antibiotic resistance and its impact on human health. Consequently, many countries have introduced stricter regulations governing antibiotic use in livestock farming. For instance, on January 28, 2022, the European Union implemented a new law prohibiting the routine feeding of antibiotics to farmed animals. Such regulations often restrict the types of antibiotics that can be employed, thereby constraining the growth of the antibiotic market in animal agriculture.

Segment Analysis

The global feed antibiotics market is segmented based on type, animal, mode of delivery, end-user and region.

Rising Demand Tetracyclines for Effectiveness against Various Bacteria

Tetracyclines, a class of antibiotics known for their wide-ranging effectiveness against various bacteria, play a crucial role in preventing and treating bacterial infections in animals. They excel in managing respiratory, gastrointestinal, and skin infections in animals. Regulatory agencies, including the FDA, have approved numerous tetracycline antibiotics for use in animal agriculture, underscoring their safety and suitability for this purpose. This regulatory approval instills confidence in their safety and efficacy.

Tetracyclines have a long history of successful use in veterinary medicine. Their effectiveness in controlling and preventing. Their versatile administration methods, including through feed, water, or injections, provide farmers with the flexibility to cater to the specific needs of animals and the diseases they face, making them a convenient and trusted option.

Source: DataM Intelligence Analysis (2023)

Geographical Penetration

Asia-Pcific's Growing Feed Industry

The region has embraced modern and intensive farming practices to maximize animal production efficiency. According to a study published in February 2020 by Dongguan University of Technology, Dongguan, China, in-feed antibiotic use altered behaviors of Oxytetracycline, sulfamerazine, and ciprofloxacin, as well as related antibiotic resistance genes during the composting of swine manure.

Asia-Pacific has experienced significant population growth, urbanization, and rising incomes. This has led to increased demand for animal-based protein products, such as meat, milk, and eggs. The Department of Animal Husbandry and Dairying reports that India is the world's top producer of milk. Milk production increased by 5.81% annually between 2019-2020 and 2020-21, reaching 198.44 million tonnes and 209.96 million tonnes, respectively. This rising demand for animal-derived products needs large amounts of feed antibiotics.

Key players in the feed and agriculture sectors have established a strong presence in the Asia Pacific, boosting market growth. The key players of feed antibiotics present in Asia-Pacific are Bayer Health Care AG, Virbac Animal Health, Merck Animal Health, Elanco Animal Health, etc. These companies are investing in R&D infrastructure and continuously introducing various feed additives including feed yeast. Hence, the presence of major companies acts as a key trend for the feed yeast market growth in that region.

Source: DataM Intelligence Analysis (2023)

Competitive Landscape

The major global players include Merck & Co., Inc, Zoetis Services LLC, Virbac, Phibro Animal Health Corporation, Vetoquinol, Ceva, Kyoritsuseiyaku Corporation, Inovet, MEGAMIX and Dechra Pharmaceuticals PLC.

COVID-19 Impact Analysis

COVID Impact

The pandemic disrupted global supply chains, affecting the production and distribution of feed antibiotics. This led to shortages and delays in the availability of feed antibiotics in some regions, impacting farmers' ability to maintain animal health. COVID-19 heightened consumer awareness of food safety and hygiene. This led to increased demand for products from animals raised with responsible antibiotic use or raised without antibiotics. As a result, some farmers and producers shifted towards antibiotic-free or reduced-antibiotic practices.

Concerns about antibiotic resistance have led to increased regulatory scrutiny of antibiotic use in animal agriculture. Some regions implemented stricter regulations during the pandemic, further influencing antibiotic use practices in livestock. The economic challenges brought by the pandemic, including reduced demand for certain animal products and increased production costs, made farmers more conscious of their expenses. This prompted some to reevaluate their antibiotic use and explore cost-effective alternatives.

Russia- Ukraine War Impact

Ukraine is a significant producer of agricultural commodities, including grains and animal feed ingredients. The conflict has disrupted the agricultural supply chain in the region, potentially affecting the availability and prices of feed ingredients used in animal agriculture, including those related to feed antibiotics. The conflict disrupted international trade routes and agreements, affecting the export and import of animal products and feed ingredients.

The war has led to economic instability in Ukraine and neighboring regions. Economic uncertainties affect consumer demand for animal products, which in turn can influence the production practices and antibiotic use in animal agriculture. As a response to supply chain disruptions caused by the conflict, some regions or countries may seek to diversify their sources of feed ingredients and animal products. This diversification can impact the distribution and use of feed antibiotics.

By Type

Tetracyclines
Penicillins
Sulfonamides
Macrolides
Aminoglycosides
Cephalosporins
Others

By Animal

Ruminants
Poultry
Swine
Aquaculture
Horses
Pets
Others

By Mode of Delivery

Premixes
Oral Powder
Oral Solution
Injection
Others

By End-User

Veterinary Hospitals
Homecare
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In July 2022, Virbac, dedicated to animal health, introduced TENOTRYL (enrofloxacin) injectable solution in the United States and expanded its product line to offer veterinarians and their clients, cattle and swine producers, a strong bench of new alternatives to enhance the health of livestock and, ultimately, their profitability.
In November 2021, Kemin, a manufacturer of ingredients for several industries, including human/animal health and nutrition, pet food, aquaculture etc. introduced a new product in Europe called TOXFIN CARE. This product was designed to protect animal organs and tissue from potential mycotoxin harm to prevent performance and productivity loss.
In July 2020, Trianni and Zoetis, an animal health company, announced an agreement, to create a transgenic antibody discovery platform for use in animal health.

Why Purchase the Report?

To visualize the global feed antibiotics market segmentation based on type, animal, mode of delivery, end-user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of Feed Antibiotics market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global feed antibiotics market report would provide approximately 77 tables, 69 figures and 181 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Type
3.2.Snippet by Animal
3.3.Snippet by Mode of Delivery
3.4.Snippet by End-user
3.5.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Rising Demand for Animal-derived Food Products
  - 4.1.1.2.Increasing Investment in Animal Health Expenditure
- 4.1.2.Restraints
  - 4.1.2.1.Growing Resistance to Antibiotics
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Type

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2.Market Attractiveness Index, By Type
7.2.Tetracyclines*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Penicillins
7.4.Sulfonamides
7.5.Macrolides
7.6.Aminoglycosides
7.7.Cephalosporins
7.8.Others

8.By Animal

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 8.1.2.Market Attractiveness Index, By Animal
8.2.Ruminants*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Poultry
8.4.Swine
8.5. Aquaculture
8.6.Horses
8.7.Pets
8.8.Others

9.By Mode of Delivery

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 9.1.2.Market Attractiveness Index, By Mode of Delivery
9.2.Premixes*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Oral Powder
9.4.Oral Solution
9.5.Injection
9.6.Others

10.By End-User

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2.Market Attractiveness Index, By End-User
10.2.Veterinary Hospitals*
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Homecare
10.4.Others

11.By Region

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2.Market Attractiveness Index, By Region
11.2.North America
- 11.2.1.Introduction
- 11.2.2.Key Region-Specific Dynamics
- 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1.U.S.
  - 11.2.7.2.Canada
  - 11.2.7.3.Mexico
11.3.Europe
- 11.3.1.Introduction
- 11.3.2.Key Region-Specific Dynamics
- 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1.Germany
  - 11.3.7.2.UK
  - 11.3.7.3.France
  - 11.3.7.4.Italy
  - 11.3.7.5.Russia
  - 11.3.7.6.Rest of Europe
11.4.South America
- 11.4.1.Introduction
- 11.4.2.Key Region-Specific Dynamics
- 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1.Brazil
  - 11.4.7.2.Argentina
  - 11.4.7.3.Rest of South America
11.5.Asia-Pacific
- 11.5.1.Introduction
- 11.5.2.Key Region-Specific Dynamics
- 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1.China
  - 11.5.7.2.India
  - 11.5.7.3.Japan
  - 11.5.7.4.Australia
  - 11.5.7.5.Rest of Asia-Pacific
11.6.Middle East and Africa
- 11.6.1.Introduction
- 11.6.2.Key Region-Specific Dynamics
- 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12.Competitive Landscape

12.1.Competitive Scenario
12.2.Market Positioning/Share Analysis
12.3.Mergers and Acquisitions Analysis

13.Company Profiles

13.1.Merck & Co., Inc.*
- 13.1.1.Company Overview
- 13.1.2.Product Portfolio and Description
- 13.1.3.Financial Overview
- 13.1.4.Recent Developments
13.2.Zoetis Services LLC.
13.3.Virbac.
13.4.Phibro Animal Health Corporation
13.5.Vetoquinol
13.6.Ceva
13.7.Kyoritsuseiyaku Corporation
13.8.Inovet
13.9.MEGAMIX
13.10.Dechra Pharmaceuticals PLC LIST NOT EXHAUSTIVE

14.Appendix

14.1.About Us and Services
14.2.Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

饲料抗生素市场 - 2023-2030

Feed Antibiotics Market - 2023-2030

目录

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按类型

第 8 章：依动物分类

第 9 章：依交付方式

第 10 章：最终用户

第 11 章：按地区

第 12 章：竞争格局

第 13 章：公司简介

第 14 章：附录